Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Pathologic Complete Response × Clofarabine × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 37 Precursor Cell Lymphoblastic Leukemia-Lymphoma 26 Leukemia 26 Myelodysplastic Syndromes 18 Recurrence 8 Lymphoma, Non-Hodgkin 8 Congenital Abnormalities 8 Leukemia, Myelomonocytic, Chronic 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia, Biphenotypic, Acute 5 Hodgkin Disease 5 Lymphoma 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4 Leukemia, Megakaryoblastic, Acute 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Leukemia, Erythroblastic, Acute 4 Burkitt Lymphoma 4 Neoplasms 3 Multiple Myeloma 3 Leukemia, Myelomonocytic, Juvenile 3 Neoplasm, Residual 2 Lymphoma, Mantle-Cell 2 Lymphoma, Large-Cell, Immunoblastic 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Eosinophilic, Acute 2

Interventions

temsirolimus 1 sargramostim 1 ruxolitinib 1 rucaparib 1 pazopanib 1 olaparib 1 eltrombopag 1 cc-486 1 Surveys and Questionnaires 1 Nivolumab 1 Monatide (IMS 3015) 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Doxorubicin 1 Docetaxel 1 Diphenhydramine 1 Cytarabine 1 Cyclophosphamide 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡